
Research on gene therapy for rare inherited disease reduces costly, regular treatment
The early-stage study published last year found that three of the men being treated for Fabry disease were able to stop using enzyme-replacement therapy — which costs about $300,000 annually — once they started on the 'one-time' gene therapy.
Dr. Michael West, a co-author and kidney specialist in Halifax, says the overall savings have been $3.7 million, against research costs to date of about $4 million — which was largely provided by the federal Canadian Institutes of Health Research.
Fabry disease is a rare disorder that leaves the body unable to produce the correct version of an enzyme that breaks down fatty materials — leading to major damage to vital organs and shortened lifespans. Some people suffer various symptoms including pain in their hands and feet, intestinal problems and chronic fatigue.
The gene therapy uses the stem cells taken from the men's bone marrow to deliver a replacement copy of the faulty gene.
The research team wrote in the Journal of Clinical and Translational Medicine last year that one of the men with advanced kidney disease saw his condition stabilize, and the researchers also found that none of the men had major events such as heart attacks or kidney failure caused by Fabry over the last five years, West said.
'These patients are still producing more of the needed enzymes than they did prior to the gene therapy,' said the 72-year-old physician, who works at the Queen Elizabeth II Health Sciences Centre in Halifax and is a professor at Dalhousie University.
West said in other instances of gene therapy there's been instances of severe side effects from procedures, including the development of various forms of cancer.
However, West said since the men received their gene therapy for Fabry between 2016 and 2018, there has been just two instances of side effects, neither of which were a direct result of the therapy itself.
Rather, in one case, a chemotherapy drug used to 'make space' in bone marrow for grafting in modified cells caused a man's white blood cell count to fall. He was treated with antibiotics for a potential infection and recovered, West said.
In a second case, a man developed a large bruise in his leg, which the researchers believe was due to possible side effects of the chemotherapy drug.
West said while the research needs to go to larger-scale studies before it becomes conventional treatment, he believes it's worth pursuing due in part to the costs and 'the burden to patients' of the existing therapy.
The specialist said that conventional enzyme-replacement therapy has to occur every two weeks, requiring approximately two hours for each treatment.
Out of the roughly 540 people with Fabry in Canada, the researcher says about 100 are in Nova Scotia.
It's believed the first person with the genetic mutation can be traced back to a French woman who immigrated to Lunenburg, N.S., in the colonial era, and her descendants carried the faulty gene through 18 generations that followed.
'Currently, there's some cases in Ontario, there's some in British Columbia, there's some in the U.K., some cases in Florida, but they all originated from here and they share the same mutation,' West said.
West said the ultimate cost of gene therapy per patient has yet to be determined, as it first would have to be approved by the major regulatory agencies as an accepted treatment.
But he said one option for inherited genetic diseases, where there is a relatively small group of patients, would be for government research agencies to develop and own the treatment themselves, and then earn fees to provide the treatments to other national health systems.
West said he realizes the sample size is small, and the goal is now to create a similar study with 25 to 30 patients, including women, over a two- to three-year period.
This report by The Canadian Press was first published July 4, 2025.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBC
a day ago
- CBC
After a decade of death, Canadian scientists say they've found the sea star killer
Social Sharing Scientists say they have found the cause behind the disease that turns vibrant, 24-armed sea stars into puddles of goo. Melanie Prentice, a research scientist at the Hakai Institute, is part of a team that has spent years investigating the cause of this disease. Their research was published on Monday in the journal Nature Ecology and Evolution. "The agent is a bacteria. It's called Vibrio pectinicida," Prentice told CBC News. After a decade of these creatures being pushed to the brink of extinction, experts say this is the first step in a road to recovery, not just for this species, but for a critical support in humanity's defence against climate change. Twisted arms that walk away The most affected species are sunflower sea stars, which once boasted a range along the west coast of North America, from Baja California to Alaska. Then, in 2013, a mass die-off occurred from sea star wasting disease. And it's a gruesome end. "Their arms kind of twist back on themselves, so they get kind of into puzzle pieces," said Alyssa Gehman, a marine disease ecologist who is also part of the Hakai Institute research team. They then tend to lose their arms, and then, "their arms will sort of walk away from their bodies." Soon after, Gehman says that lesions form and the sea stars dissolve and die. The paper estimates that more than 87 per cent of sunflower sea stars in northern parts of the west coast have been killed. In the southern habitat ranges, the species is considered functionally extinct. "When it first happened, it was just fields and fields of puddles of dying sea star goo," said Sara Hamilton, science co-ordinator for the Oregon Kelp Alliance. Hamilton was not involved in the research. "It was like something out of a horror movie." The hunt for the star killer Multiple theories identifying the cause either didn't pan out or were disproven. What the team did in this case was take healthy sea stars into the lab and expose them to infection. They did this over several years to try and isolate the cause. Gehman explained the process: "We take body fluid or tissue from a sick star and then we put that experimentally into other sea stars that we know are healthy." The paper's result was that 92 per cent of these exposures worked in transmitting the disease to the healthy star — killing it within 20 days. These experiments also revealed that Vibrio pectinicida was the most likely culprit. Experts are impressed with the paper's diligence and effort. "They didn't just stop when they found one level of evidence — they went and found a second level of evidence and a third level of evidence," said Hamilton, from Oregon Kelp Alliance. Amanda Bates, ocean conservation professor at the University of Victoria, also said "there's a pathway — essentially that you isolate disease agents and link them to being a cause of an outbreak — and this research team followed those processes perfectly." Hope for recovery Knowing the cause provides hope for restoration efforts, experts say. "Now we can go out and actually do tests and see the actual prevalence of this pathogen in the field," said Gehman. Furthermore, any captive breeding programs that are trying to restore sea star populations can now screen and test those populations before putting them back into a risky environment. Hamilton agrees. "That's one of the things we're most worried about with some of these recovery efforts," she said. "If we do captive breeding and outplant, we certainly don't want to introduce … a new outbreak of the disease." The lost decade Bates, who has seen this disease as far back as 2009, is cautious about the rush to recovery. "While we know disease impacts us as humans, I think we often forget that it impacts wildlife," she told CBC News. "We're a decade on since that really big mass mortality event, and we still don't have pycnopodia [sunflower sea stars] recovering in many places." Hamilton said the reintroduction of sunflower sea stars will be valuable because of what their absence has meant for ecosystems. Sea urchin populations have gone up — which also means kelp forests have been decimated. "Urchins are kind of like the goats of the ocean," she said. "They'll eat anything, they just mow things down." Restoring the sea star means kelp forests might once again thrive. This will likely mean improvements to biodiversity, food, tourism as well as serve as coastline defences against erosion and storms supercharged by climate change. "It's definitely our ally in the climate crisis," Prentice said. "I think when we're talking about sea star wasting disease, we're not just talking about the sea star species — which we love in their own right — but entire marine ecosystems that have collapsed because of this epidemic."


CBC
3 days ago
- CBC
Close encounter with great white shark near Halifax sparks awe, disbelief
A Dalhousie University student studying marine biology is sharing a breathtaking photo of a great white shark she took while on a recent research expedition off the coast of Halifax. Geraldine Fernandez snapped the picture Wednesday from a cage atop a boat operated by Atlantic Shark Expeditions near Sambro, a rural fishing community in the Halifax Regional Municipality. The male shark can be seen rising out of the water, staring almost directly at the camera, with his mouth agape and his teeth showing. For some, the image may be menacing. But for Fernandez, who is studying to become a shark biologist, coming up close and personal with the shark was closer to love at first bite. "The whole interaction was [one of] the most elegant, graceful and natural interactions that I have personally ever had with a shark," she said Friday in an interview with CBC's Mainstreet Halifax."It was able to show its size and its power without even doing anything. "People think they're these mindless animals that just attack, and, honestly, all it was doing was checking out the people, being a little curious, and I just got really lucky that day." 'Once-in-a-lifetime opportunity' When the image was shared on social media, many of the people commenting thought it had to be the product of artificial intelligence. But it came from a camera that Fernandez had attached to a pole. The shark was being monitored from a cage above, where she was stationed, and by divers underwater. "This encounter was extremely unique," said Neil Hammerschlag, the founder and president of Atlantic Shark Expeditions. His company regularly works with researchers like Fernandez. It also offers shark tours for civilians in Halifax and Yarmouth at various times of the year. "The other great whites we've seen this season, and there's been a handful of them, they've all been really cautious," Hammerschlag said. "This one stuck around for hours, they had no interest in the bait … was more interested in looking at the cage, rubbing up against the cage … and looking at what people were doing on the boat." Fernandez has been obsessed with sharks since she was young. As a summer research student with Dalhousie's Future of Marine Ecosystems Lab, she's been collecting data for a new method of monitoring sharks, which involves using a tool called a "shark bar" to measure the size of sharks in the water. Her close encounter with the great white shark is more proof she's on the right track. "It definitely felt like a once-in-a-lifetime opportunity," she said. "All it's done is just put more drive in me to continue my research and continue with shark exploration."


National Observer
4 days ago
- National Observer
Is Canada's pollution database hiding toxic spills in plain sight?
Canada's federal database for tracking the toxic chemicals companies and some government facilities dump into the environment is "really very misleading," researchers say. The National Pollutant Release Inventory (NPRI) is a federal database that tracks emissions of more than 300 chemicals from thousands of factories, oil and gas wells, wastewater treatment plants, airports and other industrial facilities scattered across the country. The data are meant to help Canadians determine which chemicals that industrial facilities are releasing into the environment, whether they pose a threat and track if those amounts are increasing or not. But some experts say that quantities alone are not enough to help Canadians keep their health and the environment safe. "Quantity alone is one way to measure trends, but it doesn't account for the relative toxicity of any given compound released to the environment," explained Tony Walker, a professor at Dalhousie University and former environmental consultant. For instance, his lab analyzed NPRI data on the 10 largest chemical releases in Nova Scotia, using 2015 data. The study found that list didn't reflect the actual risks chemicals posed to people in the province. That's because the top 10 chemicals released in the province were less dangerous than other products that companies released in smaller quantities, but which could have more severe impacts. The database currently doesn't offer this kind of interpretation — instead, users need to find and analyse the toxicity themselves — rendering it "virtually meaningless" to the general public, said Walker. Reporting thresholds also problematic Still, some advocates say that efforts to include relative toxicity in the NPRI's data analysis could detract from more urgent problems with the system — namely, that it doesn't track enough things, nor track things well enough, as it is. The data help Canadians determine which chemicals that industrial facilities are releasing into the environment, whether they pose a threat and track if those amounts are increasing, but some experts say quantities alone are not enough. "It would become even harder than it already is to expand the NPRI if they included relative toxicity," said Elaine MacDonald, director of Healthy Communities for Ecojustice. "Proposals to add substances receive a lot of industry pushback as it is." "Reporting thresholds have always been too high, and certainly aren't being used to address the cumulative exposures that occur in hotspots such as Chemical Valley," Cassie Barker, toxics program manager at Environmental Defence, added in an email. The NPRI was created in 1993 to help the government track pollution. Its structure generally mirrors its US equivalent, the EPA's toxics release inventory, explained John Jackson, who works with the Citizen's Network on Waste Management and joined consultations on creating the NPRI. The idea was to make it easier for regulators and the public to use data from both systems, though in practice Canada included more facilities, such as wastewater treatment plants, and potentially polluting facilities with more than 10 full-time employees. Some facilities, such as university labs or drycleaners, are generally exempted from the reporting rule. That leaves plenty of gaps. Take the 10-employee threshold, which in practice means that hundreds of small industrial facilities using toxic chemicals don't need to report. Fracking operations are also exempted from reporting requirements, despite the well-documented health and environmental impacts linked to fracking chemicals. Earlier this year, the government added 131 individual PFAS chemicals to the list, a move environmental groups said was a good step forward, but isn't enough to capture the full impact of the class of about 16,000 chemicals, said Fe de Leon, researcher at the Canadian Environmental Law Association. The reporting threshold for the chemicals is also too high, particularly because even small quantities of the chemicals can be dangerous. Jackson added that Carney's push to cut government spending by 7.5 per cent for the 2026-27 fiscal year, 10 per cent the following year and 15 per cent in 2028-29 could also hurt the NPRI's ability to function effectively — let alone add new types of analysis to the database. A spokesperson for Environment and Climate Change Canada said in an emailed statement the ministry has taken early steps toward including relative toxic impacts of chemicals it tracks, and "continues to analyze the NPRI data from a variety of perspectives, including health and environmental impacts of NPRI substances, to build on what has already been started. Still, Jackson was clear it's imperative for Canada to keep the database. "The NPRI is really important. There is no other place that gives us Canada-wide, facility-specific data on what they dump or what they send off-site to a dump somewhere else. It's an incredibly important thing. And because it's so important, we are dedicated to making it better all the time. So it's not to get rid of it, but to keep making it better.'